Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Non-Small Cell Lung Cancer Drugs Price Analysis and Strategies - 2016 - Research and Markets

Research and Markets
Posted on: 04 Nov 16

Research and Markets has announced the addition of the "Non-Small Cell Lung Cancer Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Non-Small Cell Lung Cancer Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Non-Small Cell Lung Cancer market.

The research answers the following questions:

  • What are the key drugs marketed for Non-Small Cell Lung Cancer and their clinical attributes?
  • How are they positioned in the Global Non-Small Cell Lung Cancer market?
  • What are the unit prices and annual treatment cost for Non-Small Cell Lung Cancer therapies in different countries?
  • What are the drug pricing trends and how are they expected to change in the future?
  • How are the drug pricing and reimbursement landscape different by countries?
  • What are the unmet needs in the global Non-Small Cell Lung Cancer drugs market?
  • What would be the ideal pricing strategy for a new pipeline therapy for Non-Small Cell Lung Cancer?

Research Scope:

Non-Small Cell Lung Cancer Treatment Options - Identify key drugs marketed and prescribed for Non-Small Cell Lung Cancer in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company

Non-Small Cell Lung Cancer Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Non-Small Cell Lung Cancer

Market Positioning - Identify how drugs are clinically and commercially positioned in the global Non-Small Cell Lung Cancer market

Non-Small Cell Lung Cancer Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Non-Small Cell Lung Cancer in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021

Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan

Non-Small Cell Lung Cancer New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan

For more information about this report visit http://www.researchandmarkets.com/research/g6l59c/nonsmall_cell

View source version on businesswire.com: http://www.businesswire.com/news/home/20161104005307/en/

Business Wire
www.businesswire.com

Last updated on: 04/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.